SEC62 and cancer: As potentially underlying molecular mechanisms, in vitro studies showed that SEC62 drives cancer metastasis by activating the MAPK/ATF2/UCA1 axis [28], mediating UPR-induced autophagy activation [27], and limiting calcium efflux across the ER membrane [19,26].